Medical - Healthcare Information Services
Build Your Comparison
Side-by-side financial analysisStock Comparison
FORA vs CSGP vs JPM vs ICE vs BAC
Revenue, margins, valuation, and 5-year total return — side by side.
Real Estate - Services
Banks - Diversified
Financial - Data & Stock Exchanges
Banks - Diversified
FORA vs CSGP vs JPM vs ICE vs BAC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Real Estate - Services | Banks - Diversified | Financial - Data & Stock Exchanges | Banks - Diversified |
| Market Cap | $68M | $12.77B | $908.57B | $75.83B | $424.14B |
| Revenue (TTM) | $30M | $3.41B | $280.33B | $12.64B | $191.57B |
| Net Income (TTM) | $-5M | $25M | $57.05B | $3.30B | $30.51B |
| Gross Margin | 46.8% | 77.4% | 60.0% | 61.9% | 56.1% |
| Operating Margin | -13.4% | -0.8% | 25.9% | 38.7% | 19.7% |
| Forward P/E | — | 22.1x | 14.6x | 16.5x | 12.6x |
| Total Debt | $12K | $1.14B | $942.38B | $20.28B | $365.90B |
| Cash & Equiv. | $13M | $1.73B | $343.34B | $837M | $231.84B |
FORA vs CSGP vs JPM vs ICE vs BAC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Forian Inc. (FORA) | 100 | 21.5 | -78.5% |
| CoStar Group, Inc. (CSGP) | 100 | 42.1 | -57.9% |
| JPMorgan Chase & Co. (JPM) | 100 | 205.8 | +105.8% |
| Intercontinental Ex… (ICE) | 100 | 141.6 | +41.6% |
| Bank of America Cor… (BAC) | 100 | 138.2 | +38.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FORA vs CSGP vs JPM vs ICE vs BAC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FORA has the current edge in this matchup, primarily because of its strength in growth exposure and sleep-well-at-night.
- Rev growth 50.1%, EPS growth 23.0%, 3Y rev CAGR 22.6%
- Lower volatility, beta 0.21, Low D/E 0.0%, current ratio 2.97x
- Beta 0.21, current ratio 2.97x
- 50.1% revenue growth vs BAC's -0.5%
Among these 5 stocks, CSGP doesn't own a clear edge in any measured category.
JPM is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 15 yrs, beta 0.87, yield 1.8%
- 481.2% 10Y total return vs BAC's 371.6%
- NIM 2.2% vs BAC's 1.8%
- 1.8% yield, 15-year raise streak, vs BAC's 2.3%, (2 stocks pay no dividend)
ICE is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- 26.1% margin vs FORA's -17.0%
- 2.3% ROA vs FORA's -11.8%, ROIC 7.5% vs -7.5%
BAC ranks third and is worth considering specifically for valuation efficiency.
- PEG 0.82 vs ICE's 1.86
- Lower P/E (12.6x vs 16.5x), PEG 0.82 vs 1.86
- +27.2% vs CSGP's -62.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 50.1% revenue growth vs BAC's -0.5% | |
| Value | Lower P/E (12.6x vs 16.5x), PEG 0.82 vs 1.86 | |
| Quality / Margins | 26.1% margin vs FORA's -17.0% | |
| Stability / Safety | Beta 0.21 vs JPM's 0.87, lower leverage | |
| Dividends | 1.8% yield, 15-year raise streak, vs BAC's 2.3%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +27.2% vs CSGP's -62.1% | |
| Efficiency (ROA) | 2.3% ROA vs FORA's -11.8%, ROIC 7.5% vs -7.5% |
FORA vs CSGP vs JPM vs ICE vs BAC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FORA vs CSGP vs JPM vs ICE vs BAC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CSGP leads in 1 of 6 categories
BAC leads 1 • ICE leads 1 • JPM leads 1 • FORA leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CSGP leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 9328.3x FORA's $30M. ICE is the more profitable business, keeping 26.1% of every revenue dollar as net income compared to FORA's -17.0%. On growth, CSGP holds the edge at +22.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $30M | $3.4B | $280.3B | $12.6B | $191.6B |
| EBITDAEarnings before interest/tax | -$4M | $278M | $81.4B | $6.5B | $40.0B |
| Net IncomeAfter-tax profit | -$5M | $25M | $57.0B | $3.3B | $30.5B |
| Free Cash FlowCash after capex | $2M | $241M | $100.9B | $4.3B | $12.6B |
| Gross MarginGross profit ÷ Revenue | +46.8% | +77.4% | +60.0% | +61.9% | +56.1% |
| Operating MarginEBIT ÷ Revenue | -13.4% | -0.8% | +25.9% | +38.7% | +19.7% |
| Net MarginNet income ÷ Revenue | -17.0% | +0.7% | +20.4% | +26.1% | +15.9% |
| FCF MarginFCF ÷ Revenue | +7.8% | +7.1% | +36.0% | +33.9% | +6.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.9% | +22.5% | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -2.0% | +127.7% | +16.0% | +23.1% | +18.3% |
Valuation Metrics
BAC leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, BAC trades at a 99% valuation discount to CSGP's 1814.5x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.92x vs ICE's 2.61x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $68M | $12.8B | $908.6B | $75.8B | $424.1B |
| Enterprise ValueMkt cap + debt − cash | $55M | $12.2B | $1.51T | $95.3B | $558.2B |
| Trailing P/EPrice ÷ TTM EPS | -23.48x | 1814.46x | 16.22x | 23.20x | 14.71x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 22.11x | 14.60x | 16.52x | 12.60x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.92x | 2.61x | 0.96x |
| EV / EBITDAEnterprise value multiple | — | 71.63x | 18.52x | 14.76x | 13.95x |
| Price / SalesMarket cap ÷ Revenue | 2.24x | 3.93x | 3.25x | 6.00x | 2.21x |
| Price / BookPrice ÷ Book value/share | 2.27x | 1.52x | 2.51x | 2.64x | 1.40x |
| Price / FCFMarket cap ÷ FCF | 23.49x | 311.35x | 9.01x | 17.68x | 33.63x |
Profitability & Efficiency
ICE leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-17 for FORA. FORA carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -17.2% | +0.3% | +15.9% | +11.6% | +10.1% |
| ROA (TTM)Return on assets | -11.8% | +0.2% | +1.3% | +2.3% | +0.9% |
| ROICReturn on invested capital | -7.5% | -0.9% | +4.5% | +7.5% | +3.5% |
| ROCEReturn on capital employed | -8.2% | -0.8% | +8.9% | +9.5% | +4.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 | 9 | 7 |
| Debt / EquityFinancial leverage | 0.00x | 0.14x | 2.60x | 0.70x | 1.21x |
| Net DebtTotal debt minus cash | -$13M | -$589M | $599.0B | $19.4B | $134.1B |
| Cash & Equiv.Liquid assets | $13M | $1.7B | $343.3B | $837M | $231.8B |
| Total DebtShort + long-term debt | $12,137 | $1.1B | $942.4B | $20.3B | $365.9B |
| Interest CoverageEBIT ÷ Interest expense | -48.78x | 1.58x | 0.74x | 6.53x | 0.48x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $23,548 today (with dividends reinvested), compared to $1,735 for FORA. Over the past 12 months, BAC leads with a +27.2% total return vs CSGP's -62.1%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.7% vs CSGP's -29.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +2.4% | -54.1% | +0.8% | -15.7% | +1.4% |
| 1-Year ReturnPast 12 months | +2.4% | -62.1% | +20.9% | -24.4% | +27.2% |
| 3-Year ReturnCumulative with dividends | -7.3% | -64.7% | +138.8% | +24.3% | +105.5% |
| 5-Year ReturnCumulative with dividends | -82.7% | -65.7% | +135.5% | +26.4% | +57.4% |
| 10-Year ReturnCumulative with dividends | -90.5% | +43.4% | +481.2% | +192.5% | +371.6% |
| CAGR (3Y)Annualised 3-year return | -2.5% | -29.3% | +33.7% | +7.5% | +27.1% |
Risk & Volatility
Evenly matched — FORA and BAC each lead in 1 of 2 comparable metrics.
Risk & Volatility
FORA is the less volatile stock with a 0.21 beta — it tends to amplify market swings less than JPM's 0.87 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BAC currently trades 96.9% from its 52-week high vs CSGP's 30.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.21x | 0.45x | 0.87x | 0.38x | 0.83x |
| 52-Week HighHighest price in past year | $2.71 | $97.43 | $338.09 | $189.35 | $57.98 |
| 52-Week LowLowest price in past year | $1.64 | $29.53 | $269.72 | $132.84 | $44.21 |
| % of 52W HighCurrent price vs 52-week peak | +80.1% | +30.9% | +96.2% | +70.7% | +96.9% |
| RSI (14)Momentum oscillator 0–100 | 63.8 | 31.0 | 72.1 | 29.6 | 70.9 |
| Avg Volume (50D)Average daily shares traded | 40K | 7.0M | 7.4M | 3.3M | 32.4M |
Analyst Outlook
Evenly matched — JPM and BAC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CSGP as "Buy", JPM as "Buy", ICE as "Buy", BAC as "Buy". Consensus price targets imply 103.1% upside for CSGP (target: $61) vs 4.5% for JPM (target: $340). For income investors, BAC offers the higher dividend yield at 2.25% vs ICE's 1.45%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $61.18 | $339.75 | $194.00 | $61.13 |
| # AnalystsCovering analysts | — | 25 | 61 | 36 | 54 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.8% | +1.4% | +2.3% |
| Dividend StreakConsecutive years of raises | — | — | 15 | 13 | 12 |
| Dividend / ShareAnnual DPS | — | — | $5.95 | $1.93 | $1.27 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | +4.5% | +3.8% | +1.8% | +5.1% |
CSGP leads in 1 of 6 categories (Income & Cash Flow). BAC leads in 1 (Valuation Metrics). 2 tied.
FORA vs CSGP vs JPM vs ICE vs BAC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FORA or CSGP or JPM or ICE or BAC a better buy right now?
For growth investors, Forian Inc.
(FORA) is the stronger pick with 50. 1% revenue growth year-over-year, versus -0. 5% for Bank of America Corporation (BAC). Bank of America Corporation (BAC) offers the better valuation at 14. 7x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate CoStar Group, Inc. (CSGP) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FORA or CSGP or JPM or ICE or BAC?
On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.
7x versus CoStar Group, Inc. at 1814. 5x. On forward P/E, Bank of America Corporation is actually cheaper at 12. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Bank of America Corporation wins at 0. 82x versus Intercontinental Exchange, Inc. 's 1. 86x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — FORA or CSGP or JPM or ICE or BAC?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +135. 5%, compared to -82. 7% for Forian Inc. (FORA). Over 10 years, the gap is even starker: JPM returned +481. 2% versus FORA's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FORA or CSGP or JPM or ICE or BAC?
By beta (market sensitivity over 5 years), Forian Inc.
(FORA) is the lower-risk stock at 0. 21β versus JPMorgan Chase & Co. 's 0. 87β — meaning JPM is approximately 313% more volatile than FORA relative to the S&P 500. On balance sheet safety, Forian Inc. (FORA) carries a lower debt/equity ratio of 0% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — FORA or CSGP or JPM or ICE or BAC?
By revenue growth (latest reported year), Forian Inc.
(FORA) is pulling ahead at 50. 1% versus -0. 5% for Bank of America Corporation (BAC). On earnings-per-share growth, the picture is similar: Forian Inc. grew EPS 23. 0% year-over-year, compared to -95. 1% for CoStar Group, Inc.. Over a 3-year CAGR, FORA leads at 22. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FORA or CSGP or JPM or ICE or BAC?
Intercontinental Exchange, Inc.
(ICE) is the more profitable company, earning 26. 1% net margin versus -9. 5% for Forian Inc. — meaning it keeps 26. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ICE leads at 38. 7% versus -8. 2% for FORA. At the gross margin level — before operating expenses — CSGP leads at 75. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FORA or CSGP or JPM or ICE or BAC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Bank of America Corporation (BAC) is the more undervalued stock at a PEG of 0. 82x versus Intercontinental Exchange, Inc. 's 1. 86x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank of America Corporation (BAC) trades at 12. 6x forward P/E versus 22. 1x for CoStar Group, Inc. — 9. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CSGP: 103. 1% to $61. 18.
08Which pays a better dividend — FORA or CSGP or JPM or ICE or BAC?
In this comparison, BAC (2.
3% yield), JPM (1. 8% yield), ICE (1. 4% yield) pay a dividend. FORA, CSGP do not pay a meaningful dividend and should not be held primarily for income.
09Is FORA or CSGP or JPM or ICE or BAC better for a retirement portfolio?
For long-horizon retirement investors, Intercontinental Exchange, Inc.
(ICE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 38), 1. 4% yield, +192. 5% 10Y return). Both have compounded well over 10 years (ICE: +192. 5%, CSGP: +43. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FORA and CSGP and JPM and ICE and BAC?
These companies operate in different sectors (FORA (Healthcare) and CSGP (Real Estate) and JPM (Financial Services) and ICE (Financial Services) and BAC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: FORA is a small-cap high-growth stock; CSGP is a mid-cap high-growth stock; JPM is a large-cap deep-value stock; ICE is a mid-cap quality compounder stock; BAC is a large-cap deep-value stock. JPM, ICE, BAC pay a dividend while FORA, CSGP do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.